Феликса

Феликса (Febuxostat) is an oral medication used to manage high uric acid levels associated with gout. This non-purine selective xanthine oxidase inhibitor helps prevent gout attacks by lowering uric acid production. Suitable for adults, it provides an alternative for those intolerant to allopurinol.

Febuxostat is primarily used to treat chronic hyperuricemia in conditions like gout, where high uric acid levels lead to painful joint inflammation. It works by reducing the production of uric acid in the body, helping to prevent gout flares and tophi formation. This medication is often prescribed when diet and lifestyle changes are insufficient.

Febuxostat helps maintain lower uric acid levels in the bloodstream, which may reduce the frequency of gout attacks over time. Some users report improved mobility and reduced joint discomfort as uric acid levels stabilize. Individual responses may vary, and consistent use is important for effectiveness.

Keep this medication in a cool, dry place away from direct sunlight. Store it securely, out of reach of children and pets. If you experience unusual symptoms or allergic reactions while taking febuxostat, consult a healthcare professional promptly. Regular follow-ups may be recommended to monitor uric acid levels.

Febuxostat may interact with medications that affect liver enzymes, such as certain antibiotics or antifungals. Combining it with drugs that increase uric acid levels, like thiazide diuretics, may reduce its effectiveness. Alcohol and high-purine foods can also interfere with treatment outcomes.